How many insider declarations has Mandel-Brehm Josh filed?

Mandel-Brehm Josh has filed 3 public insider declarations with SEC (Form 4).

What is Mandel-Brehm Josh's role?

Mandel-Brehm Josh's reported role is not specified by the regulator across the filings.

Which companies does Mandel-Brehm Josh report trades for?

Mandel-Brehm Josh reports trades for Camp4 Therapeutics Corp.

What is Mandel-Brehm Josh's declared buy vs sell volume?

Across the available history, declared buys total 18k€ and disposals 0.

← Executives ★ Sign in to follow

MJ

Mandel-Brehm Josh

CEO

·SEC (Form 4)

Camp4 Therapeutics Corp

0

Total declarations

0

Company

€17,892

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the detailed record of transactions filed by Mandel-Brehm Josh. Officer active across 1 company, notably Camp4 Therapeutics Corp. In total, 3 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €18k. History available since 11 September 2025. The latest transaction was disclosed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Mandel-Brehm Josh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Camp4 Therapeutics Corp (US)

Declarations3 total

▲

Mandel-Brehm Josh

Chief Executive OfficerExecutives3 Aug 2026Camp4 Therapeutics Corp

$10,80957SEC ↗

6,551 shares@ US$1.650.0060% mcap52.4% of flowCommon StockSEC:0001628280-26-053505:0

Canonical exit: 1 Nov 2026 (T+90)

▲

Mandel-Brehm Josh

Chief Executive OfficerExecutives11 Sept 2025Camp4 Therapeutics Corp

$9,99952SEC ↗

6,060 shares@ US$1.65100.0% of flowCommon StockSEC:0001927058-25-000002:0

Canonical exit: 10 Dec 2025 (T+90)

●

Mandel-Brehm Josh

Chief Executive OfficerExecutives15 Oct 2024Camp4 Therapeutics Corp

22SEC ↗

605 sharesCommon StockSEC:0001104659-24-108699:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

MJ

Mandel-Brehm Josh

CEO

·SEC (Form 4)

Camp4 Therapeutics Corp

0

Total declarations

0

Company

€17,892

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the detailed record of transactions filed by Mandel-Brehm Josh. Officer active across 1 company, notably Camp4 Therapeutics Corp. In total, 3 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €18k. History available since 11 September 2025. The latest transaction was disclosed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.